High frequency of aneuploidy defines ulcerative colitis-associated carcinomas: A prognostic comparison to sporadic colorectal carcinomas

Annals of Surgery

Volumn 252, Issue 1, 2010, Pages 74-83

  Gerling, Marco ^a   Meyer, Karl F ^a   Fuchs, Katrin ^a   Igl, Bernd W ^b   Fritzsche, Britta ^a   Ziegler, Andreas ^b   Bader, F ^a   Kujath, Peter ^a   Schimmelpenning, Hendrik ^c   Bruch, Hans Peter ^a   Roblick, Uwe J ^a   Habermann, Jens K ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c Klinikum Neustadt   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER SURVIVAL; COLORECTAL CARCINOMA; DIPLOIDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; ULCERATIVE COLITIS; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; COMPLICATION; GENETICS; MIDDLE AGED; PATHOLOGY;

DNA;

AGED; ANEUPLOIDY; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 77954084906     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181deb664     Document Type: Article

References (36)

1. Bernstein CN, Blanchard JF, Kliewer E, et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001;91: 854-862.
2. Sjoqvist U. Dysplasia in ulcerative colitis\clinical consequences? Langen-becks Arch Surg. 2004;389:354-360.
3. Lynch DA, Lobo AJ, Sobala GM, et al. Failure of colonoscopic surveillance in ulcerative colitis. Gut. 1993;34:1075-1080.
4. Riddell RH. How reliable/valid is dysplasia in identifying at-risk patients with ulcerative colitis? J Gastrointest Surg. 1998;2:314-317.
5. Habermann J, Lenander C, Roblick UJ, et al. Ulcerative colitis and colorectal carcinoma: DNA-profile, laminin-5 gamma2 chain and cyclin A expression as early markers for risk assessment. Scand J Gastroenterol. 2001;36:751-758.
6. Lofberg R, Brostrom O, Karlen P, et al. DNA aneuploidy in ulcerative colitis: reproducibility, topographic distribution, and relation to dysplasia. Gastroen-terology. 1992;102(4 pt 1):1149-1154.
7. Rubin CE, Haggitt RC, Burmer GC, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gas-troenterology. 1992;103:1611-1620.
8. Fozard JB, Quirke P, Dixon MF, et al. DNA aneuploidy in ulcerative colitis. Gut. 1986;27:1414-1418.
9. Holzmann K, Klump B, Borchard F, et al. Comparative analysis of histology, DNA content, p53 and Ki-ras mutations in colectomy specimens with longstanding ulcerative colitis. Int J Cancer. 1998;76:1-6.
10. Klump B, Holzmann K, Kuhn A, et al. Distribution of cell populations with DNA aneuploidy and p53 protein expression in ulcerative colitis. Eur J Gastroenterol Hepatol. 1997;9:789-794.
11. Clausen OP, Andersen SN, Stroomkjaer H, et al. A strategy combining flow sorting and comparative genomic hybridization for studying genetic aberrations at different stages of colorectal tumorigenesis in ulcerative colitis. Cytometry. 2001;43:46-54.
12. Levine DS, Rabinovitch PS, Haggitt RC, et al. Distribution of aneuploid cell populations in ulcerative colitis with dysplasia or cancer. Gastroenterology. 1991;101:1198-1210.
13. Makiyama K, Tokunaga M, Itsuno M, et al. DNA aneuploidy in a case of rectosigmoid adenocarcinoma complicated by ulcerative colitis. J Gastroen-terol. 1995;30:258-263.
14. Burmer GC, Rabinovitch PS, Loeb LA. Frequency and spectrum of c-Ki-ras mutations in human sporadic colon carcinoma, carcinomas arising in ulcer-ative colitis, and pancreatic adenocarcinoma. Environ Health Perspect. 1991; 93:27-31.
15. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759-767.
16. Kouri M. DNA ploidy of colorectal carcinoma by tumour site, gender and history of noncolorectal malignancies. Oncology. 1993;50:41-45.
17. Sinicrope FA, Rego RL, Halling KC, et al. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients. Gastroenter-ology. 2006;131:729-737.
18. Araujo SE, Bernardo WM, Habr-Gama A, et al. DNA ploidy status and prognosis in colorectal cancer: a meta-analysis of published data. Dis Colon Rectum. 2007;50:1800-1810.
19. Goel A, Nagasaka T, Arnold CN, et al. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology. 2007;132:127-138.
20. Pohl C, Hombach A, Kruis W. Chronic inflammatory bowel disease and cancer. Hepatogastroenterology. 2000;47:57-70.
21. Delaunoit T, Limburg PJ, Goldberg RM, et al. Colorectal cancer prognosis among patients with inflammatory bowel disease. Clin Gastroenterol Hepa-tol. 2006;4:335-342.
22. Aarnio M, Mustonen H, Mecklin JP, et al. Prognosis of colorectal cancer varies in different high-risk conditions. Ann Med. 1998;30:75-80.
23. Chavez-Uribe E, Cameselle-Teijeiro J, Vinuela JE, et al. Hypoploidy defines patients with poor prognosis in breast cancer. Oncol Rep. 2007;17:1109-1114.
24. Yildirim-Assaf S, Coumbos A, Hopfenmuller W, et al. The prognostic significance of determining DNA content in breast cancer by DNA image cytometry: the role of high grade aneuploidy in node negative breast cancer. J Clin Pathol. 2007;60:649-655.
25. Habermann JK, Doering J, Hautaniemi S, et al. The gene expression signature of genomic instability in breast cancer is an independent predictor of clinical outcome. Int J Cancer. 2008;124:1552-1564.
26. Half EE, Bresalier RS. Clinical management of hereditary colorectal cancer syndromes. Curr Opin Gastroenterol. 2004;20:32-42.
27. Danque PO, Chen HB, Patil J, et al. Image analysis versus flow cytometry for DNA ploidy quantitation of solid tumors: a comparison of six methods of sample preparation. Mod Pathol. 1993;6:270-275.
28. Auer GU, Caspersson TO, Wallgren AS. DNA content and survival in mammary carcinoma. Anal Quant Cytol. 1980;2:161-165.
29. Fleiss JL. Measuring nominal scale agreement among many raters. Psychol Bull. 1971;76:378-382.
30. Suzuki K, Muto T, Masaki T, et al. Microspectrophotometric DNA analysis in ulcerative colitis with special reference to its application in diagnosis of carcinoma and dysplasia. Gut. 1990;31:1266-1270.
31. Paganelli GM, Lalli E, Facchini A, et al. Flow cytometry and in vitro tritiated thymidine labeling in normal rectal mucosa of patients at high risk of colorectal cancer. Am J Gastroenterol. 1994;89:220-224.
32. Frei JV. Hereditary nonpolyposis colorectal cancer (Lynch syndrome II). Diploid malignancies with prolonged survival. Cancer. 1992;69:1108-1111.
33. Kuester D, Dalicho S, Monkemuller K, et al. Synchronous multifocal colo-rectal carcinoma in a patient with delayed diagnosis of ulcerative pancolitis. Pathol Res Pract. 2008;204:905-910.
34. Saccani Jotti G, Fontanesi M, Orsi N, et al. DNA content in human colon cancer and non-neoplastic adjacent mucosa. Int J Biol Markers. 1995;10:11-16.
35. Berczi C, Bocsi J, Bartha I, et al. Prognostic value of DNA ploidy status in patients with rectal cancer. Anticancer Res. 2002;22(6B):3737-3741.
36. Collins PD, Mpofu C, Watson AJ, et al. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane Database Syst Rev. 2006:CD000279.